economictimes.com | Aug. 8, 2023, 4:12 p.m.
After Zomato, Gland Pharma, what could be the next turnaround story? Rahul Shah answers
| Zomato
| Gland pharma
| Rahul shah
Read more
business-standard.com | Jan. 23, 2023, 8:13 p.m.
Gland Pharma Q3 net declines 15% to Rs 232 cr due to production delays
| Gland pharma q3
Read more
business-standard.com | Jan. 6, 2023, 10:45 p.m.
Drug firm Gland Pharma to fully acquire Europe-based Cenexi Group
| Drug
| Gland pharma
Read more
business-standard.com | Dec. 13, 2022, 3:22 p.m.
Fosun's sale of Gland Pharma to become India's biggest pharma deal: Report
| Fosun
| Gland
| India
Read more
economictimes.com | Dec. 13, 2022, 7:27 a.m.
Fosun taps big buyout funds for Gland Pharma
| Fosun
Read more
business-standard.com | Nov. 30, 2022, 8:05 a.m.
Stocks to Watch: Zomato, SBI, Adani Group, Britannia, ONGC, Gland Pharma
| Zomato
| Sbi
| Adani group
| Britannia
| Ongc
Read more
economictimes.com | Nov. 30, 2022, 7:25 a.m.
Stocks in the news: Wipro, Britannia, Cipla, IDFC, Biocon and Gland Pharma
| Wipro
| Britannia
| Cipla
| Idfc
| Biocon
| Gland
Read more
business-standard.com | Nov. 29, 2022, 7:37 p.m.
Fosun plans to sell of India's $3.8 billion drug maker Gland Pharma
| Fosun
| India
Read more
business-standard.com | Nov. 29, 2022, 1:39 p.m.
Fosun reportedly planning sale of India's $3.6 billion Gland Pharma
| Fosun
| India
| Gland
Read more
business-standard.com | Oct. 27, 2022, 10:25 p.m.
Uncertainty on revenue growth, margin outlook hits Gland Pharma stock
| Uncertainty
| Gland pharma
Read more
business-standard.com | Oct. 27, 2022, 9:55 a.m.
Gland Pharma plunges 13%, hits 52-week low on disappointing Q2 results
| Gland pharma
Read more
business-standard.com | Oct. 26, 2022, 6:13 p.m.
Gland Pharma's Q2 net dips 20.14% to Rs 241.24 cr; India revenue down 42%
| Gland pharma
| India
Read more
business-standard.com | Oct. 14, 2022, 8:16 a.m.
Here's why Mehul Kothari recommends buying Gland Pharma, Indian Oil
| Mehul kothari
| Gland pharma
| Indian
Read more
economictimes.com | Sept. 24, 2022, 9:44 a.m.
Prime Wealth 6 must-reads of the week: 6 stocks with up to 41% upside potential, why Gland Pharma is this week's stock pick
| Gland pharma
Read more
business-standard.com | July 21, 2022, 10:04 a.m.
Gland Pharma slips 10%, hits 52-week low on disappointing Q1 results
| Gland pharma
Read more
business-standard.com | June 21, 2022, 7:06 p.m.
Gland Pharma rides high on valuation comfort, strong growth prospects
| Gland pharma
Read more